Study Details

Naturalistic Pharmacotherapy for Youth Depression — LEAP

Lynn L. DeBar, Principal Investigator
Gregory N. Clarke, Christina Gullion, David H. Smith, Frances L. Lynch, Co-Investigators

 Depression is one of the most common mental disorders among children and adolescents, affecting as many as 25% of adolescents by age 18. Little information exists regarding the services for youth depression in typical health care settings, particularly managed care. This study will examine antidepressant treatment in a general adolescent population (ages 12 to 18) in Kaiser Permanente Northwest. Specifically, this study will examine whether outcomes are better for depressed children receiving "adequate" antidepressant drug treatment. The study also will analyze factors that may affect how well antidepressant drug treatment works. The project is focused on drug therapy but also will study other treatment services received by these youth. Information will be collected through electronic medical records and interviews of the youth and parents.
Funding source: National Institute of Mental Health

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente